NEWTYN MANAGEMENT, LLC TCR2 Therapeutics Inc. Transaction History

NEWTYN MANAGEMENT, LLC portfolio value:

$1.08M
portfolio value

NEWTYN MANAGEMENT, LLC quarter portfolio value change:

-37.93%
quarter

TCR2 Therapeutics Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -13.39% -92.79K shares -929K $1.8 600K
Q2 2022 share Increase 0.00% 692.79K shares 2.00M $2.9 692.79K